{"contentid": 488012, "importid": NaN, "name": "Doctors call for clarity amid opposing AstraZeneca vaccine views", "introduction": "Health authorities in European Union (EU) countries have intervened amid concerns around the safety of the AstraZeneca COVID-19 vaccine.", "content": "<p>Health authorities in European Union (EU) countries have intervened amid concerns around the safety of the AstraZeneca (LSE: AZN) COVID-19 vaccine.</p>\n<p>Denmark has temporarily stopped using the vaccine, developed by the Anglo-Swedish drugmaker along with the University of Oxford, following reports of a small number of blood clots and one death.</p>\n<p><span class=\"pullQuote\">\"Information available so far indicates that the number of thromboembolic events in vaccinated people is no higher than that seen in the general population\"</span>It is not yet known whether these episodes were linked to the vaccine, a batch of which has also been suspended from usage in Austria after a person was diagnosed with multiple thrombosis and died 10 days after vaccination, and another recipient was hospitalized with pulmonary embolism.</p>\n<p>The latter is now recovering. As of March 9, two other reports of thromboembolic event cases had been received for this batch.</p>\n<p>According to the European Medicines Agency&rsquo;s Pharmacovigilance Risk Assessment Committee (PRAC), there is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine.</p>\n<p>Batch ABV5300 was delivered to 17 EU countries and comprises one million doses of the vaccine. Some EU countries have also subsequently suspended this batch as a precautionary measure, while a full investigation is ongoing.</p>\n<p>&ldquo;Although a quality defect is considered unlikely at this stage, the batch quality is being investigated,&rdquo; an EMA statement reads. &ldquo;EMA&rsquo;s safety committee PRAC is reviewing this issue; it is investigating the cases reported with the batch as well as all other cases of thromboembolic events, and other conditions related to blood clots, reported post-vaccination.</p>\n<p>&ldquo;The information available so far indicates that the number of thromboembolic events in vaccinated people is no higher than that seen in the general population.&rdquo;</p>\n<p>Meanwhile, a group that claims to be made up of scientists and doctors has issued an open letter calling on the EMA to answer urgent safety questions regarding COVID-19 vaccines, or withdraw the vaccines&rsquo; authorization.</p>\n<p>The group, which calls itself Doctors 4 Covid Ethics, highlighted that there are serious concerns that the approval of the COVID-19 vaccines by the EMA was premature.</p>\n<p>The letter describes serious potential consequences of COVID-19 vaccine technology, warning of possible autoimmune reactions, blood clotting abnormalities, stroke and internal bleeding, &ldquo;including in the brain, spinal cord and heart.&rdquo;</p>\n<p>&ldquo;Should all such evidence not be available&rdquo;, the authors write, &ldquo;we demand that approval for use of the gene-based vaccines be withdrawn until all the above issues have been properly addressed by the exercise of due diligence by the EMA.&rdquo;</p>\n<p>&nbsp;</p>\n<p>Image: Rob Acket</p>", "date": "2021-03-11 12:58:00", "meta_title": NaN, "meta_keywords": "vaccine, batch, AstraZeneca, COVID-, countries, safety, thromboembolic, European, doctors, concerns, number, call, clarity, events, opposing, views, Health", "meta_description": "Health authorities in European Union (EU) countries have intervened amid concerns around the safety of the AstraZeneca COVID-19 vaccine.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-11 12:44:56", "updated": "2021-03-11 13:40:22", "access": NaN, "url": "https://www.thepharmaletter.com/article/doctors-call-for-clarity-amid-opposing-astrazeneca-vaccine-views", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "ema_building-credit_rob_acket.jpg", "image2id": "ema_building-credit_rob_acket_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, European Medicines Agency, Focus On, Regulation", "geography_tag": "Austria, Denmark, Europe", "company_tag": "AstraZeneca", "drug_tag": "COVID-19 Vaccine AstraZeneca", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-11 12:58:00"}